PPARD has been reported to accelerate colorectal tumorigenesis, progression, and invasion (Liu et al., 2019), it could effectively predict the prognosis of HCC patients as an independent prognostic signature (Sun et al., 2021). This evidence concerns the gene PPARD and hepatocellular carcinoma.